Oxurion NV: Oxurion Announces Preclinical Presentation on THR-149 at KININ2022
Leuven, BELGIUM, Boston, MA, US - JUNE 7, 2022 - Oxurion NV(Euronext Brussels: OXUR), a clinical stage biopharmaceutical company developing next generation standard of care ophthalmic